Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1048-2026

Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS)

Fresenius Kabi USA, LLCNorth Andover, MA, United StatesReported Jan 21, 2026 · 5 months ago
Legal News Analyst ·

Reason for recall

Emphasizing instructions for LVP duration programming located in the IFU.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Ivenix Infusion System (IIS), LVP Software:LVP-SW-0005
    UDI 00811505030122

What the firm is doing

An URGENT MEDICAL DEVICE CORRECTION notification dated 11/21/25 was sent to consignees notifying them of this safety alert. The notification reiterates instructions for administering infusions included in the device's IFU. Fresenius Kabi asks consignees to disseminate the notification to all users and any facilities where devices may have been further distributed for their awareness. Consignees with any questions are to contact Customer Support by email at Ivenix_support@fresenius-kabi.com or by phone at 1-855-354-6387.

DistributionShow details

US Nationwide distribution in the states of CA, CO, FL, GA, ID, IL, MD, MI, MI, MN, MS, NE, NJ, NV, OK, OR, SC, TX, VA, WA, WI, WI.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls